Orthocell Competitors and Similar CompaniesClear all

Orthocell's competitors and similar companies include Celling Biosciences, Allurion Technologies, Cardiva Medical and ReCor Medical.
Orthocell
Orthocell
Orthocell is a company that develops devices for regenerating mobility of tendon, cartilage, and soft tissue.
Celling Biosciences
Celling Biosciences
Celling Biosciences is a company developing point-of-care systems, surgical techniques, and technology platforms that create the optimal environment for regenerative cell therapies.
Allurion Technologies
Allurion Technologies
Allurion Technologies is a company that provides a weight loss platform.
Cardiva Medical
Cardiva Medical
Cardiva Medical designs and develops vascular access management products that facilitate rapid hemostasis following diagnostic and interventional endovascular procedures.
ReCor Medical
ReCor Medical
ReCor Medical is a medical device company that designs and manufactures the Paradise System, an ultrasound ablation system for renal denervation (RDN).
Founding Date
Founding Date
2006
Founding Date
2013
Founding Date
2009
Founding Date
2002
Founding Date
2009
Type
Type
Public
Type
Private
Type
Public
Type
Private
Type
Subsidiary
Tags
Locations
Locations
Murdoch, AU HQ
Locations
Austin, US HQ
Curitiba, BR
Dubai, AE
Locations
Natick, US HQ
Locations
Santa Clara, US HQ
Locations
Palo Alto, US HQ
Sandwich, GB
Employees
Employees
N/A
Employees
47
Employees
266
Employees
2411% increase
Employees
3111% increase
Valuation ($)
Valuation ($)
65.5 m
Valuation ($)
N/A
Valuation ($)
49.5 m
Valuation ($)
N/A
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
$7.6m (FY, 2025)
Revenue (est.)
N/A
Revenue (est.)
$15.2m (FY, 2025)
Revenue (est.)
N/A
Revenue (est.)
N/A
Cost of goods
Cost of goods
$2.2m (FY, 2025)
Cost of goods
N/A
Cost of goods
$5.7m (FY, 2025)
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
$5.7m (FY, 2025)
Gross profit
N/A
Gross profit
$9.6m (FY, 2025)
Gross profit
N/A
Gross profit
N/A
Net income
Net income
($8.6m) (FY, 2025)
Net income
N/A
Net income
($28.8m) (FY, 2025)
Net income
N/A
Net income
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 90.5m
Total funding raised
$ 112.7m
Total funding raised
$ 15m
For sources of this data, please see the company profile

View Company Profiles

Celling Biosciences
HQ
Austin, US
Employees
47

Celling Biosciences is a company developing point-of-care systems, surgical techniques, and technology platforms that create the optimal environment for regenerative cell therapies.

View company
Allurion Technologies
HQ
Natick, US
Employees
266

Allurion Technologies is a company that provides a weight loss platform.

View company
Cardiva Medical
HQ
Santa Clara, US
Employees
241↑ 1% increase

Cardiva Medical designs and develops vascular access management products that facilitate rapid hemostasis following diagnostic and interventional endovascular procedures.

View company
ReCor Medical
HQ
Palo Alto, US

ReCor Medical is a medical device company that designs and manufactures the Paradise System, an ultrasound ablation system for renal denervation (RDN).

View company